Revolutionizing genomic technologies
Ellis Bio is driven by a vision to produce cutting-edge epigenomic tools accessible to researchers and clinicians worldwide.
Kits for low-input DNA & fast workflows
SuperMethyl™ Max
AVAILABLE NOW
✓ 99.8% C-to-T conversion
✓ Preserve DNA like an enzyme
✓ Ideal for low-input
SuperMethyl™ Fast
ORDER NOW
✓ 35-minute total workflow
✓ Lowest cost on the market
✓Ideal for high-volume
Roche Highlights Robust Performance of Ellis Bio SuperMethyl™ Kits in New Tech Spotlight
Independent Roche evaluation shows SuperMethyl™ Max delivers the highest methylation calling accuracy in the study, producing fewer false calls than both a leading enzymatic methyl-seq (EM‑seq) method and a leading traditional bisulfite kit in low‑input cell-free DNA...
New Gentle Methyl Conversion Kit Delivers High-Accuracy Profiling from as Little as 100 pg of DNA
New commercial kit brings Nature Communications-validated methylation analysis chemistry to researchers working with low-input and cfDNA samples Cambridge, MA - Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official...
New “Ultra-Mild” Sequencing Method Fixes Long-Standing Flaws in Cancer DNA Methylation Tests
Re-engineered bisulfite chemistry overcomes decades-old limitations in methylation sequencing Cambridge, MA - Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis method, called UMBS-seq, was...